The City of Springfield will have to pay more than $500,000 to a Black Springfield Police Captain who says he was passed over ...
The trial is structured to assess the safety and efficacy of the therapy in approximately 50 ATTRv-PN subjects.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Wainzua (eplontersen) to treat adults with ...
Editas Medicine struggles with underwhelming data and lacks major partnerships. Find out why EDIT stock faces significant ...
Intellia Therapeutics (NTLA) announced the first patient has been dosed in MAGNITUDE-2, a global, pivotal Phase 3 trial of nexiguran ...
Vutrisiran improved mortality and recurrent CV risks independent of disease severity and improved several other endpoints for ...
PET/CT, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis ...
RWJBarnabas Health research were awarded a $2.4 million grant to develop technology to better manage patients presenting with heart attacks.
The Food and Drug Administration (FDA) has approved Amvuttra ® (vutrisiran) for the treatment of the cardiomyopathy of ...
Researchers at ACC suggested stratifying by age and TTR variant, plus cascade testing, could help identify those likely to ...
AI tools that analyze echocardiograms and electrocardiograms can identify those at higher risk of heart disease-related death, a study at the ACC meeting showed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results